ROIV - Roivant Sciences Ltd
Roivant Sciences Ltd Logo

ROIV - Roivant Sciences Ltd

https://roivant.com
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

None

52W High
$13.08
52W Low
$8.73
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.15
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.74
EV/Revenue (<3 favorable)
190.22
P/S (TTM) (<3 favorable)
379.75
P/B (<3 favorable)
2.03
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
26.39%
Institutions (25–75% balanced)
76.79%
Shares Outstanding
682,882,000
Float
417,616,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
23,233,000
Gross Profit (TTM)
-555,944,000
EPS (TTM)
-1.09
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-128.40%
ROE (TTM) (>15% strong)
-0.18%
EPS YoY (Quarterly) (>10% good)
-0.96
Revenue YoY (Quarterly) (>8% good)
-0.73
Momentum
Value
N/A
Previous
N/A
Trend
—
Signal Cross
No cross
As of
—